Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
48.28
-0.68 (-1.39%)
Nov 21, 2024, 11:44 AM EST - Market open
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Janux Therapeutics stock have an average target of 65.1, with a low estimate of 42 and a high estimate of 100. The average target predicts an increase of 34.84% from the current stock price of 48.28.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for JANX stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 6 | 6 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +30.49% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +107.13% | Nov 7, 2024 |
| UBS | UBS | Strong Buy Initiates $69 | Strong Buy | Initiates | $69 | +42.92% | Oct 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +107.13% | Sep 16, 2024 |
| Stifel | Stifel | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +44.99% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
13.44M
from 8.08M
Increased by 66.30%
Revenue Next Year
6.96M
from 13.44M
Decreased by -48.24%
EPS This Year
-1.23
from -1.32
EPS Next Year
-1.62
from -1.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 29.3M | 37.4M | 52.5M | ||
| Avg | 13.4M | 7.0M | 12.0M | ||
| Low | 9.9M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 262.9% | 178.0% | 654.5% | ||
| Avg | 66.3% | -48.2% | 72.0% | ||
| Low | 23.1% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.79 | -0.92 | -1.20 | ||
| Avg | -1.23 | -1.62 | -2.01 | ||
| Low | -1.38 | -2.21 | -2.77 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.